首页 产品目录 分子砌块 按反应类型 氨基甲酸酯合成 (8S,8aS,12aR)-1,3,6,7-四羟基-9,9,11-三甲基-8-(3,4,6,8-四羟基-9-氧代-9H-氧杂蒽-1-基)-8a,9,10,12a-四氢茚并[1,2-a]氧杂蒽-13(8H)-酮

(8S,8aS,12aR)-1,3,6,7-四羟基-9,9,11-三甲基-8-(3,4,6,8-四羟基-9-氧代-9H-氧杂蒽-1-基)-8a,9,10,12a-四氢茚并[1,2-a]氧杂蒽-13(8H)-酮

(8S,8aS,12aR)-1,3,6,7-tetrahydroxy-9,9,11-trimethyl-8-(3,4,6,8-tetrahydroxy-9-oxo-9H-xanthen-1-yl)-8a,9,10,12a-tetrahydroindeno[1,2-a]xanthen-13(8H)-one

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

219649-95-3

中文名称

(8S,8aS,12aR)-1,3,6,7-四羟基-9,9,11-三甲基-8-(3,4,6,8-四羟基-9-氧代-9H-氧杂蒽-1-基)-8a,9,10,12a-四氢茚并[1,2-a]氧杂蒽-13(8H)-酮

英文名称

(8S,8aS,12aR)-1,3,6,7-tetrahydroxy-9,9,11-trimethyl-8-(3,4,6,8-tetrahydroxy-9-oxo-9H-xanthen-1-yl)-8a,9,10,12a-tetrahydroindeno[1,2-a]xanthen-13(8H)-one

别名

Griffipavixanthone;Indeno[1,2-a]xanthen-13(8H)-one, 8a,9,10,12a-tetrahydro-1,3,6,7-tetrahydroxy-9,9,11-trimethyl-8-(3,4,6,8-tetrahydroxy-9-oxo-9H-xanthen-1-yl)-, (8R,8aR,12aS)-(+)-

标准英文名

(8S,8aS,12aR)-1,3,6,7-tetrahydroxy-9,9,11-trimethyl-8-(3,4,6,8-tetrahydroxy-9-oxo-9H-xanthen-1-yl)-8a,9,10,12a-tetrahydroindeno[1,2-a]xanthen-13(8H)-one

MDL No.

MFCD20260798

分子式

C36H28O12

分子量

652.61

精确分子量

652.16

SMILES

CC1=C[C@H]2C3=C4C(=O)C5=C(O)C=C(O)C=C5OC4=C(O)C(O)=C3[C@H](C3=CC(O)=C(O)C4=C3C(=O)C3=C(O)C=C(O)C=C3O4)[C@H]2C(C)(C)C1

标准SMILES

CC1CC(C)(C)[C@H]2[C@@H](C=1)C1C([C@@H]2C2=CC(O)=C(O)C3OC4=CC(O)=CC(O)=C4C(=O)C2=3)=C(O)C(O)=C2OC3=CC(O)=CC(O)=C3C(=O)C2=1

用途

Griffipavixanthone is an anticancer agent that induces apoptosis via the mitochondrial apoptotic pathway accompanied by ROS production; it also acts as a weak sucrase inhibitor (IC50: 4.58 mM).

InChIKey

KAPVRSRPLHVWCH-JNFGOLMQSA-N

安全信息

SureRoute逆合成路线

1.  219649-95-3 逆合成路线 1

—
—
ACRMAX679
219649-95-3
来源: SureRoute

2.  219649-95-3 逆合成路线 2

—
—
ACRMAX679
219649-95-3
来源: SureRoute

3.  219649-95-3 逆合成路线 3

—
—
ACRMAX679
219649-95-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手